The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy

The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy

Abstract Background There are numerous non-biologic and biologic disease-modifying anti-rheumatic drugs (bDMARDs) for rheumatoid arthritis (RA). Typical sequences of bDMARDs are not clear. Future treatment policies and trials should be informed by quantitative estimates of current treatment practice...

Full description

Bibliographic Details
Main Authors: Daniel H. Solomon, Chang Xu, Jamie Collins, Seoyoung C. Kim, Elena Losina, Vincent Yau, Fredrik D. Johansson
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Arthritis Research & Therapy
Subjects:
DMARDs
Rheumatoid arthritis
Treatment
Online Access:https://doi.org/10.1186/s13075-020-02408-4

Internet

https://doi.org/10.1186/s13075-020-02408-4

Similar Items